|
US4570630A
(en)
*
|
1983-08-03 |
1986-02-18 |
Miles Laboratories, Inc. |
Medicament inhalation device
|
|
US5161524A
(en)
*
|
1991-08-02 |
1992-11-10 |
Glaxo Inc. |
Dosage inhalator with air flow velocity regulating means
|
|
US6582728B1
(en)
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
|
GB9216038D0
(en)
*
|
1992-07-28 |
1992-09-09 |
Bespak Plc |
Dispensing apparatus for powdered medicaments
|
|
AU684754B2
(en)
*
|
1993-03-03 |
1998-01-08 |
Glaxo Wellcome Inc. |
Dry powder inhalator medicament carrier
|
|
US5388572A
(en)
*
|
1993-10-26 |
1995-02-14 |
Tenax Corporation (A Connecticut Corp.) |
Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
|
|
US5388573A
(en)
*
|
1993-12-02 |
1995-02-14 |
Tenax Corporation |
Dry powder inhalator medicament carrier
|
|
US5505194A
(en)
*
|
1994-03-23 |
1996-04-09 |
Abbott Laboratories |
Aerosol inhalation device having slideably and rotatably connected elliptical cylinder portions
|
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
|
FR2731911B1
(fr)
*
|
1995-03-20 |
1997-08-14 |
Paul Seyvos |
Dispositif qui permet d'inhaler, par la bouche, l' odeur de produits contenus dans un reservoir a des fins therapeutiques
|
|
JP3669710B2
(ja)
|
1995-12-07 |
2005-07-13 |
ヤゴ リサーチ アクチェンゲゼルシャフト |
薬理学的乾燥粉末を多数回投薬するための吸入器と吸い口
|
|
US7131441B1
(en)
|
1995-12-07 |
2006-11-07 |
Skyepharma Ag |
Inhaler for multiple dosed administration of a pharmacological dry powder
|
|
US5669378A
(en)
*
|
1995-12-21 |
1997-09-23 |
Pera; Ivo |
Inhaling device
|
|
US20030203036A1
(en)
|
2000-03-17 |
2003-10-30 |
Gordon Marc S. |
Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
|
|
CA2212430A1
(en)
*
|
1997-08-07 |
1999-02-07 |
George Volgyesi |
Inhalation device
|
|
UA73924C2
(en)
*
|
1998-10-09 |
2005-10-17 |
Nektar Therapeutics |
Device for delivering active agent formulation to lungs of human patient
|
|
DE29908593U1
(de)
|
1999-05-14 |
1999-07-22 |
Jago Research AG, Hergiswil |
Mundstück für einen Inhalator zur Abgabe eines Medikaments
|
|
EP1261316B1
(en)
|
2000-02-28 |
2008-04-23 |
PharmaKodex Limited |
Device for the delivery of oral drugs
|
|
US6595210B2
(en)
*
|
2000-11-27 |
2003-07-22 |
Unisia Jecs Corporation |
Inhalator for administering powder composition
|
|
GB2380410B
(en)
*
|
2001-10-05 |
2003-11-19 |
Alchemy Healthcare Ltd |
Apparatus for the nasal or oral delivery of a medicament
|
|
EP1483283A4
(en)
|
2002-03-13 |
2007-04-11 |
Signum Biosciences Inc |
MODULATION OF PROTEIN METHYLATION AND PHOSPHOPROTEIN PHOSPHATE
|
|
ITMO20020297A1
(it)
*
|
2002-10-16 |
2004-04-17 |
Roberto Oliva |
Inalatore per preparati monodose in capsule.
|
|
US20060045849A1
(en)
*
|
2004-08-24 |
2006-03-02 |
Farhan Taghizadeh |
Method of customizing the fragrance of nasal medications
|
|
PL370285A1
(pl)
*
|
2004-09-23 |
2006-04-03 |
Glaxosmithkline Pharmaceuticals Spółka Akcyjna |
Inhalator proszkowy
|
|
CA2601777A1
(en)
|
2005-02-03 |
2006-08-10 |
Signum Biosciences, Inc. |
Compositions and methods for enhancing cognitive function
|
|
US7923041B2
(en)
|
2005-02-03 |
2011-04-12 |
Signum Biosciences, Inc. |
Compositions and methods for enhancing cognitive function
|
|
US8653028B2
(en)
|
2005-04-29 |
2014-02-18 |
Rui Rong Yuan |
Erythropoietin-derived short peptide and its mimics as immuno/inflammatory modulators
|
|
US9345745B2
(en)
|
2005-04-29 |
2016-05-24 |
Bo Wang |
Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptides
|
|
US9585932B2
(en)
|
2005-04-29 |
2017-03-07 |
Peter C. Dowling |
Use of EPO-derived peptide fragments for the treatment of neurodegenerative disorders
|
|
US20070049641A1
(en)
*
|
2005-08-24 |
2007-03-01 |
Rabindra Tirouvanziam |
Methods for treating and monitoring inflammation and redox imbalance cystic fibrosis
|
|
US20090192227A1
(en)
*
|
2005-08-24 |
2009-07-30 |
Rabindra Tirouvanziam |
N-Acetylcysteine Compositions and Methods for Treating Acute Exacerbations of Inflammatory Lung Disease
|
|
US8227408B2
(en)
*
|
2005-09-07 |
2012-07-24 |
Neurotez, Inc. |
Leptin as an anti-amyloidogenic biologic and methods for delaying the onset and reducing Alzheimer's disease-like pathology
|
|
US9107824B2
(en)
|
2005-11-08 |
2015-08-18 |
Insmed Incorporated |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
|
|
GB0604444D0
(en)
|
2006-03-06 |
2006-04-12 |
Optinose As |
Nasal devices
|
|
AU315527S
(en)
|
2006-09-28 |
2007-08-03 |
Glaxo Group Ltd |
Inhalation device
|
|
ES2594281T3
(es)
|
2007-01-10 |
2016-12-19 |
Purdue Research Foundation |
Inhibidores polipeptídicos de HSP27 quinasa y usos de los mismos
|
|
EP2185698B1
(en)
|
2007-08-07 |
2015-04-22 |
Purdue Research Foundation |
Kinase inhibitors and uses thereof
|
|
JP2011511674A
(ja)
|
2008-02-07 |
2011-04-14 |
ユニヴァーシティ オブ ワシントン |
周方向エアロゾルデバイス
|
|
CA2725143A1
(en)
*
|
2008-05-21 |
2009-11-26 |
Neurotez, Inc. |
Methods for treating progressive cognitive disorders related to neurofibrillary tangles
|
|
CN109568740B
(zh)
*
|
2008-06-13 |
2022-05-27 |
曼金德公司 |
干粉吸入器和用于药物输送的系统
|
|
KR101884616B1
(ko)
*
|
2008-10-20 |
2018-08-06 |
모레 매트릭스 인코포레이티드 |
유착 치료 또는 예방용 폴리펩티드
|
|
WO2010054017A1
(en)
*
|
2008-11-04 |
2010-05-14 |
Nikolaos Tezapsidis |
Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amlyoid beta
|
|
AU2009324661A1
(en)
*
|
2008-12-10 |
2011-07-07 |
Purdue Research Foundation |
Cell-permeant peptide-based inhibitor of kinases
|
|
UA108856C2
(uk)
|
2009-07-24 |
2015-06-25 |
|
Пунікалін (punicalin) та пунікалагін (punicalagin) для захисту здоров'я головного мозку при нейродегенеративних розладах
|
|
WO2011017132A2
(en)
*
|
2009-07-27 |
2011-02-10 |
Purdue Research, Foundation |
Mk2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration
|
|
CA2828884C
(en)
|
2011-03-03 |
2021-04-27 |
Impel Neuropharma, Inc. |
Nasal drug delivery device
|
|
CA3042808A1
(en)
|
2011-04-12 |
2012-10-18 |
Moerae Matrix, Inc. |
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
|
|
US9890200B2
(en)
|
2011-04-12 |
2018-02-13 |
Moerae Matrix, Inc. |
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
|
|
EP2701712B1
(en)
|
2011-04-25 |
2017-06-21 |
Cornell University |
Use of uridine and deoxyuridine to treat folate-responsive pathologies
|
|
AU2012253569B2
(en)
|
2011-05-09 |
2018-02-15 |
Impel Pharmaceuticals Inc. |
Nozzles for nasal drug delivery
|
|
EP2589381B1
(en)
|
2011-11-04 |
2016-08-31 |
Rabindra Tirouvanziam |
Compositions for improving or preserving lung function in a patient with a pulmonary disorder
|
|
WO2013134636A1
(en)
|
2012-03-09 |
2013-09-12 |
Purdue Research Foundation |
Compositions and methods for delivery of kinase inhibiting peptides
|
|
DK2892524T3
(da)
|
2012-09-04 |
2021-01-25 |
Eleison Pharmaceuticals LLC |
Forebyggelse af pulmonalt kræfttilbagefald med lipid-komplekseret cisplatin
|
|
HK1222358A1
(zh)
|
2013-04-28 |
2017-06-30 |
Impel Neuropharma Inc. |
医用单位剂量容器
|
|
TWI568463B
(zh)
|
2013-07-12 |
2017-02-01 |
H 斯圖爾特 坎貝爾 |
用於吸入器之吹嘴
|
|
ES2811090T3
(es)
|
2013-09-10 |
2021-03-10 |
Univ Texas |
Terapéuticos dirigidos a proteínas truncadas de poliposis adenomatosa coli (apc)
|
|
US10336788B2
(en)
|
2014-04-17 |
2019-07-02 |
Moerae Matrix, Inc. |
Inhibition of cardiac fibrosis in myocardial infarction
|
|
USD748242S1
(en)
|
2014-07-11 |
2016-01-26 |
H. Stuart Campbell |
Inhaler mouthpiece
|
|
US10082496B2
(en)
|
2014-09-10 |
2018-09-25 |
Board Of Regents Of The University Of Texas System |
Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis
|
|
KR20170083063A
(ko)
|
2014-11-17 |
2017-07-17 |
모레 매트릭스 인코포레이티드 |
이상 섬유모세포 증식 및 세포외 기질 침착을 특징으로 하는 질병, 질환, 또는 과정의 예방 또는 치료용 조성물 및 방법
|
|
EP3229831B1
(en)
|
2014-12-10 |
2020-03-11 |
Hyperstem SA |
Methods and compositions for reducing growth, migration and invasiveness of brain cancer stem cells and improving survival of patients with brain tumors
|
|
MX2017008994A
(es)
|
2015-01-08 |
2018-09-18 |
Moerae Matrix Inc |
Formulacion de peptidos inhibidores mk2.
|
|
RU2017135072A
(ru)
|
2015-03-12 |
2019-04-10 |
Мори Матрикс, Инк. |
Применение пептидсодержащих композиций ингибитора mk2 для лечения немелкоклеточного рака легкого
|
|
HK1253373A1
(zh)
|
2015-06-10 |
2019-06-14 |
Hackensack University Medical Center |
使用替米沙坦预防和治疗移植物抗宿主病及其他同种免疫性和自体免疫性疾病
|
|
US10112948B2
(en)
|
2015-07-06 |
2018-10-30 |
The Board Of Regents Of The University Of Texas System |
Benzamide or benzamine compounds useful as anticancer agents for the treatment of human cancers
|
|
AU2016292779B2
(en)
|
2015-07-15 |
2021-05-20 |
The Board Of Regents Of The University Of Texas System |
Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis
|
|
JP6753927B2
(ja)
|
2015-09-10 |
2020-09-09 |
インペル ニューロファーマ インコーポレイテッド |
直列形経鼻送達デバイス
|
|
US11833118B2
(en)
|
2016-01-20 |
2023-12-05 |
Flurry Powders, Llc |
Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation
|
|
JP6953414B2
(ja)
|
2016-01-20 |
2021-10-27 |
フラリー パウダーズ エルエルシーFlurry Powders,Llc |
親油性成分を含む吸入に好適な分散性の噴霧乾燥粉末を製造する方法
|
|
WO2019104192A1
(en)
|
2017-11-21 |
2019-05-31 |
Impel Neuropharma, Inc. |
Intranasal device with inlet interface
|
|
JP7191099B2
(ja)
|
2017-11-21 |
2022-12-16 |
インペル ファーマシューティカルズ インコーポレイテッド |
浸漬管を備えた鼻腔内装置
|
|
CN111936140A
(zh)
|
2018-01-05 |
2020-11-13 |
英倍尔药业股份有限公司 |
通过精密鼻装置的双氢麦角胺的鼻内递送
|
|
WO2019136308A1
(en)
|
2018-01-05 |
2019-07-11 |
Impel Neuropharma, Inc. |
Intranasal delivery of olanzapine by precision olfactory device
|
|
US11517548B2
(en)
|
2018-07-19 |
2022-12-06 |
Impel Pharmaceuticals Inc. |
Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for treatment of Parkinson's Disease
|
|
JP7213991B2
(ja)
|
2019-01-03 |
2023-01-27 |
インペル ファーマシューティカルズ インコーポレイテッド |
経鼻薬送達器具
|
|
WO2020236658A1
(en)
|
2019-05-17 |
2020-11-26 |
Impel Neuropharma, Inc. |
Single-use nasal delivery device
|